These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22737648)

  • 1. Dry eye syndrome due to botulinum toxin type-A injection: guideline for prevention.
    Ozgur OK; Murariu D; Parsa AA; Parsa FD
    Hawaii J Med Public Health; 2012 May; 71(5):120-3. PubMed ID: 22737648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
    Arat YO; Yen MT
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of eyelid botulinum toxin injection on lacrimal drainage.
    Sahlin S; Chen E; Kaugesaar T; Almqvist H; Kjellberg K; Lennerstrand G
    Am J Ophthalmol; 2000 Apr; 129(4):481-6. PubMed ID: 10764857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
    Flynn TC; Carruthers JA; Carruthers JA; Clark RE
    Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased tear expression with an abnormal Schirmer's test following botulinum toxin type A for the treatment of lateral canthal rhytides.
    Matarasso SL
    Dermatol Surg; 2002 Feb; 28(2):149-52. PubMed ID: 11860426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eyelid botulinum toxin injections for the dry eye.
    Sahlin S; Linderoth R
    Dev Ophthalmol; 2008; 41():187-192. PubMed ID: 18453769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
    Ho MC; Hsu WC; Hsieh YT
    JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye.
    Serna-Ojeda JC; Nava-Castaneda A
    Acta Ophthalmol; 2017 Mar; 95(2):e132-e137. PubMed ID: 27350144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis.
    Jia Z; Lu H; Yang X; Jin X; Wu R; Zhao J; Chen L; Qi Z
    Aesthetic Plast Surg; 2016 Oct; 40(5):769-77. PubMed ID: 27495260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids.
    Matarasso SL; Matarasso A
    Plast Reconstr Surg; 2001 Jul; 108(1):208-14; discussion 215-7. PubMed ID: 11420526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet.
    Lowe NJ; Ascher B; Heckmann M; Kumar C; Fraczek S; Eadie N;
    Dermatol Surg; 2005 Mar; 31(3):257-62. PubMed ID: 15841623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
    Hui JI; Lee WW
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous crow's feet line patterns and customized botulinum toxin rejuvenating treatment.
    Cavallini M; Papagni M; Augelli F; Muti GF; Santorelli A; Raichi M
    J Cosmet Dermatol; 2022 Oct; 21(10):4294-4300. PubMed ID: 35723939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation.
    Dolar Bilge A; Sadigov F; Salar-Gomceli S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botox use in prevention of dry eyes.
    Benvenuti D
    Plast Reconstr Surg; 1998 Sep; 102(3):918. PubMed ID: 9727468
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
    Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
    Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
    Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.